- Astra gets rights to NicOx's NO-NSAIDS; deal terminated
- Nobex, GSK sign $283mm oral insulin deal; cancelled
- Glaxo, Icos develop anti-inflammatory, CV drugs; ended
- Lilly pays Icos $75mm up front to establish JV
- Bayer and GlaxoSmithKline co-promote ED drug
- Pharmacia, BatellePharma develop inhaled drug
- Millennium in giant cancer deal with Ortho Biotech
- Serono raises CHF600mm with debt financing
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.